Armstrong, CW;
Mensah, FFK;
Leandro, MJ;
Reddy, V;
Gooley, PR;
Berkovitz, S;
Cambridge, G;
(2024)
In vitro B cell experiments explore the role of CD24, CD38, and energy metabolism in ME/CFS.
Frontiers in Immunology
, 14
, Article 1178882. 10.3389/fimmu.2023.1178882.
Preview |
PDF
fimmu-14-1178882.pdf - Published Version Download (1MB) | Preview |
Abstract
Introduction: Disturbances of energy metabolism contribute to the clinical manifestations of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Previously, we found that B cells from ME/CFS patients have an increased expression of CD24, a modulator of many cellular functions including those of cell stress. The relative ability of B cells from ME/CFS patients and healthy controls (HC) to respond to rapid changes in energy demand was compared. Methods: CD24, the ectonucleotidases CD39 and CD73, the NAD-degrading enzyme CD38, and mitochondrial mass (MM) were measured following cross-linking of the B cell receptor and costimulation with either T-cell-dependent or Toll-like-receptor-9-dependent agonists. The levels of metabolites consumed/produced were measured using 1H-NMR spectroscopy and analyzed in relation to cell growth and immunophenotype. Results: Proliferating B cells from patients with ME/CFS showed a lower mitochondrial mass and a significantly increased usage of essential amino acids compared with those from HC, with a significantly delayed loss of CD24 and an increased expression of CD38 following stimulation. Discussion: The immunophenotype results suggested the triggering of a stress response in ME/CFS B cells associated with the increased usage of additional substrates to maintain necessary ATP levels. Disturbances in energy metabolism in ME/CFS B cells were thus confirmed in a dynamic in vitro model, providing the basis for further mechanistic investigations.
| Type: | Article |
|---|---|
| Title: | In vitro B cell experiments explore the role of CD24, CD38, and energy metabolism in ME/CFS |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3389/fimmu.2023.1178882 |
| Publisher version: | http://dx.doi.org/10.3389/fimmu.2023.1178882 |
| Language: | English |
| Additional information: | Copyright © 2024 Armstrong, Mensah, Leandro, Reddy, Gooley, Berkovitz and Cambridge. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| Keywords: | chronic fatigue syndrome, B cells, metabolomics, CD24, metabolism |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10186427 |
Archive Staff Only
 |
View Item |
